Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTissue Regenix Group Regulatory News (TRX)

  • This share is currently suspended. It was suspended at a price of 7.23
  • There is currently no data for TRX

Trading Update

6 Jan 2005 07:00

Torex Retail PLC06 January 2005 6 January 2005 TOREX RETAIL PLC TRADING UPDATE Torex Retail plc ("Torex Retail" or "the Group"), the UK's market leader inretail IT solutions, is pleased to announce that following the close of its yearend on 31 December 2004, it expects to report pre-tax profits ahead ofexpectations when it announces its preliminary results in February 2005. This reflects strong trading from all areas of the Group. The success of theGroup in the second half of 2004 is based upon sales of Group software productswith associated services, particularly with new contract wins for its marketleading EpoS product LUCAS. This has reinforced the changing business modelexperienced in the first half with increased software licence sales and lowerhardware revenues contributing to improved operating margins. In addition atight control on working capital has resulted in a strong cash inflow fromoperating activities. The integration of Alphameric Retail has commenced and initial findings areconsistent with pre-acquisition due diligence and the strategic rationale forthe transaction. In addition, new opportunities are being identified which isvery encouraging for 2005 and beyond. Rob Loosemore, Chairman of Torex Retail plc, commented: "I am delighted with the progress we have made in our first year as a publiccompany both in terms of financial performance and strategic development.Strong trading, particularly in the second half, together with the acquisitionof Alphameric's Retail Division provides a tremendous platform and momentum fororganic growth in 2005 and beyond. The pre-tax profits will be ahead ofexpectations which continues the long established tradition of the seniormanagement team, of not only doing what we say we will do but exceeding it." Enquiries: Torex Retail plc Citigate Dewe Rogerson Mark Pearman, Chief Executive Ginny Pulbrook / Seb Hoyle / Freida Moore Richard Thompson, Finance Director Telephone: +44 (0)20 7638 9571 Telephone: +44 (0)870 050 9900 Notes to Editors: Torex Retail, a leading European retail solutions business, floated on AIM inMarch 2004. The business is an independent supplier of electronic point of sale("EPOS") solutions and services and productivity tools to high street,convenience and petroleum retailers with an installed base of some 50,000 EPOSlicences across Europe. It has a broad base of blue-chip clients and employs700 staff in UK, Germany, Belgium, Holland and Eire. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
24th May 201812:12 pmRNSResult of AGM
2nd May 20187:00 amRNSTRX BioSurgery GPO agreement with Premier, Inc.
27th Apr 20187:00 amRNSPosting of Annual Report and Notice of AGM
24th Apr 20187:00 amRNSDermaPure manufacturing at CellRight Facility
19th Apr 20183:29 pmRNSHolding(s) in Company
5th Apr 20187:17 amEQSHardman & Co Research: Tissue Regenix (TRX): CellRight hits the right note
26th Mar 20187:00 amRNSAnnual results for period ended 31 December 2017
16th Mar 20183:40 pmRNSPublication of Financial Results
8th Mar 20187:15 amRNSHardman & Co: Full-year 2017 - what to look for
6th Mar 20187:00 amRNSLong term distribution agreement with Arthrex, Inc
26th Feb 20187:00 amRNSNotice of Results
26th Feb 20187:00 amRNSLaunch of BioSurgery and new distributor agreement
2nd Feb 20187:00 amRNSIssue of Equity
22nd Dec 20179:30 amRNSIssue of Equity
1st Dec 20177:00 amRNSDirectorate Change
1st Dec 20177:00 amRNSIssue of Equity
2nd Nov 20177:00 amRNSAppointment of CEO
18th Oct 20177:00 amRNSDirectorate Change
11th Oct 20177:15 amRNSHardman Research: Dual revenue stream growth
28th Sep 20173:15 pmRNSUnaudited Interim Results
8th Sep 20177:00 amRNSNotice of Results
5th Sep 20173:52 pmRNSNotification Of Major Holdings
30th Aug 20175:15 pmRNSIssue of Equity
16th Aug 201712:22 pmRNSHolding(s) in Company
11th Aug 20173:45 pmRNSHolding(s) in Company
11th Aug 20173:37 pmRNSHolding(s) in Company
10th Aug 20174:30 pmRNSHolding(s) in Company
10th Aug 20172:45 pmRNSHolding(s) in Company
10th Aug 20171:10 pmRNSHardman Research: CellRight transforming US growth
10th Aug 201710:10 amRNSHolding(s) in Company
9th Aug 20173:00 pmRNSHolding(s) in Company
9th Aug 20172:30 pmRNSDirector/PDMR Shareholding
8th Aug 20171:41 pmRNSResults of General Meeting and Total Voting Rights
21st Jul 20176:00 pmRNSCirc re.CellRight Acquisition
21st Jul 20178:05 amRNSSuccessful fundraising of £40 million
20th Jul 20176:03 pmRNSProposed Acquisition and Placing
30th Jun 201712:00 pmRNSResult of AGM
2nd Jun 20177:00 amRNSAnnual results for period ended 31 December 2016
31st May 201710:46 amRNSPotential Acquisition Update
19th May 201711:35 amRNSPotential Acquisition
3rd Apr 20177:00 amRNSIssue of Equity
13th Mar 20177:10 amRNSHardman Research: Addressing woundcare in the US
1st Mar 20177:00 amRNSInnovative Technology Contract Awarded
2nd Feb 20177:00 amRNSDermaPure® added to the Federal Supply Schedule
6th Jan 20177:00 amRNSDirectorate Change
9th Dec 20167:15 amRNSHardman Research: a/c change: Not simply 11/12ths
7th Dec 20161:04 pmRNSTR1- NOTIFICATION OF MAJOR INTEREST IN SHARES
6th Dec 20167:00 amRNSDermaPure secures GPO agreement with Premier, Inc.
28th Nov 20167:05 amRNSOrthoPureT XT update
22nd Nov 20167:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.